Menopause · Nov 10, 2026
Validation of the Perimenopause Symptom Scale (Peri-SS) for digital self-assessment: psychometric evaluation among US women aged 35 to 59 years
By Xu Y, Ilyich I, Prentice C et al.
Objective: Perimenopause is an under-recognized transition poorly measured by existing tools, which often overlook symptoms characteristic of this phase. To address this, we developed and validated the Perimenopause Symptom Scale (Peri-SS): a concise, phase-specific, psychometrically robust instrument for digital self-assessment and research use among US women aged 35-59 who self-reported being in perimenopause. Methods: We conducted a longitudinal validation study with 1,255 US women aged 35-59 (633 self-identified as perimenopausal) recruited via Prolific. Participants completed the Peri-SS, Menopause Rating Scale (MRS), and EuroQol 5-Dimension, 5-Level (EQ-5D-5L) questionnaire at baseline and 7-14 days later. Following COSMIN guidelines, we assessed structural validity, internal consistency, test-retest reliability, criterion and construct validity, and responsiveness to change. Results: The Peri-SS demonstrated strong psychometric performance. Confirmatory factor analysis confirmed a four-domain structure (vasomotor, psychological, sexual, physical), with excellent model fit (CFI=0.932, RMSEA=0.069). Internal consistency was excellent (α=0.90 overall; domain range 0.73-0.86), and test-retest reliability was high (ICC=0.82). Criterion validity was strong, with Peri-SS scores highly correlated with Menopause Rating Scale ( r =0.88). Construct validity was supported through moderate correlations with EQ-5D-5L utilities (ρ=−0.50) and effective discrimination between groups by age, reproductive stage, and hormone therapy use. The scale was also responsive to symptom changes over time (η²=0.277). Conclusions: The Peri-SS is a reliable, valid, responsive tool for assessing perimenopausal symptom burden. Its concise format and strong psychometric performance make it well-suited for research, clinical care, and digital health applications.
doi.org/10.1097/gme.0000000000002948Open accessPubMed 43012501Biomarkers